---
title: "Efemoral Medical granted Breakthrough Device designation"
date: "2024-02-14T15:38:33.000Z"
publishedDate: "14 février 2024"
summary: "Efemoral Medical today announced that the US Food and Drug Administration (FDA) has granted its novel Efemoral vascular scaffold system (EVSS) Breakthrough Device status for the treatment of de novo or restenotic lesions of the infrapopliteal arteries in patients with chronic limb-threatening ischaemia (CLTI). A press release states the EVSS offers a new approach to [&#8230;] The post Efemoral Medical granted Breakthrough Device designation appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/efemoral-medical-granted-breakthrough-device-designation/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2024-02-14-efemoral-medical-granted-breakthrough-device-designation"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2024/02/Efemoral-logo-web.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/efemoral-medical-granted-breakthrough-device-designation/"
---

![Efemoral Medical granted Breakthrough Device designation](https://vascularnews.com/wp-content/uploads/sites/7/2024/02/Efemoral-logo-web.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/efemoral-medical-granted-breakthrough-device-designation/*

## L’essentiel

Efemoral Medical today announced that the US Food and Drug Administration (FDA) has granted its novel Efemoral vascular scaffold system (EVSS) Breakthrough Device status for the treatment of de novo or restenotic lesions of the infrapopliteal arteries in patients with chronic limb-threatening ischaemia (CLTI). A press release states the EVSS offers a new approach to [&#8230;] The post Efemoral Medical granted Breakthrough Device designation appeared first on Vascular News .

## Lien source

https://vascularnews.com/efemoral-medical-granted-breakthrough-device-designation/
